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a b s t r a c t
Objective: This study was aimed at assessing the effect of maternal smoking during pregnancy on
metabolic cardiovascular risk factors in early adulthood in a Brazilian birth cohort, after controlling for
possible confounding variables and health behaviors in early adulthood.
Methods: In 1982, the maternity hospitals in Pelotas, southern Brazil, were visited and all births were
identiﬁed. Those livebirths whose family lived in the urban area of the city were studied prospectively.
In 2004–2005, we attempted to follow the whole cohort, the subjects were interviewed, examined and
blood sample was collected. The following outcomes were studied: blood pressure; HDL cholesterol;
triglycerides; random blood glucose and C-reactive protein. To explore the effect of maternal smoking,
we adjusted the coefﬁcients for the following possible mediators: perinatal factors (low birthweight and
preterm births); adult behavioral factors (physical activity, dietary pattern, intake of fat and ﬁber, and
tobacco smoking) and adult anthropometry (body mass index and waist circumference).
Results: In 2004–2005, we interviewed 4297 subjects, with a follow-up rate of 77.4%. The only signiﬁcant ﬁnding in the unadjusted analyses was lower HDL cholesterol among females. After adjustment for
lifestyle variables in early adulthood, birthweight and waist circumference, the difference in HDL levels
between offspring of smokers and non-smokers reduced from −2.10 mg/dL (95% conﬁdence interval:
−3.39; −0.80) to −1.03 mg/dL (−2.35; 0.30).
Conclusion: Evidence that maternal smoking during pregnancy programs offspring metabolic cardiovascular risk factors are scarce, and reported associations are likely due to postnatal exposure to lifestyle
patterns.

1. Introduction
Smoking is the second leading risk factor for global mortality
[1]. In addition, exposure to maternal smoking during pregnancy is
related to short and long-term health risks, ranging from intrauterine growth restriction [2,3] to psychological problems. [4] However,
the evidence concerning the programming of cardiovascular diseases by maternal smoking during pregnancy is not clear-cut. A
meta-analysis that included nine studies reported a small increase
in blood pressure (0.62 mmHg; 95% conﬁdence interval: 0.19; 1.05)
among subjects prenatally exposed to smoking. [5] With respect to
blood lipids, Jaddoe et al. [6] observed that maternal smoking in
pregnancy is associated with a rise in total cholesterol levels and a
tendency towards an adverse lipoprotein proﬁle, with a decrease in
HDL and an increase in LDL levels. Power et al. [8] observed that off-

spring of smokers had higher triglyceride levels, whereas their HDL
cholesterol was lower than for adults who had not been exposed in
utero.
Evidence on long-term effects of smoking during pregnancy
on the offspring is limited to observational studies, and therefore
may be affected by selection bias and confounding. Several strategies were used in the literature to overcome this problem. Brion
et al. [7] reported that the effects of paternal and maternal smoking on blood pressure at 7 years were similar, although one would
expect a stronger association with maternal smoking, as the latter
is more strongly related to intrauterine growth than environmental tobacco exposure resulting from paternal smoking. [3] These
authors suggest that maternal smoking may be a marker for familial
factors related to blood pressure, rather than a cause of fetal programming. Reinforcing such evidence, the associations described
by Power et al. [8] vanished when the estimates were also adjusted
for behavioral variables in adulthood, such as physical activity, diet
and tobacco smoking, suggesting that the observed effect of maternal smoking in pregnancy on metabolic cardiovascular risk factors

was mediated by healthy behaviors in adulthood and not due to a
prenatal programming.
The present study was aimed at assessing the effect of maternal
smoking in the pregnancy on metabolic cardiovascular risk factors in early adulthood in a Brazilian birth cohort followed up for
22–23 years, after controlling for possible confounding variables
and health behaviors in early adulthood.
2. Methods
In 1982, the ﬁve maternity hospitals in Pelotas, a southern
Brazilian city, were visited daily and all births were identiﬁed. The
5914 liveborns whose family lived in the urban area were examined
and their mothers interviewed. These subjects have been followedup for several times [9].
From October 2004 to August 2005, all households located in
urban area of the city were visited in search of subjects born in 1982
and belonging to the cohort. For those who had not been located
and were not known to have died, we used the last known address
and existing databases (including universities, secondary schools
and telephone directories) for another attempt. Subjects answered
a questionnaire and were examined. At the end of the interview,
the subjects were invited to visit the research laboratory to donate
a blood sample, collected by venous puncture.
The following metabolic risk factors of cardiovascular diseases
were assessed:
• Blood pressure: blood pressure was measured at the beginning
and at the end of the interview, using a digital wrist sphygmomanometer (Omron HEM-629). The mean values were used in
the analyses.
• HDL cholesterol was measured using an ultrasensitive direct
method, with a Selectra 2 analyzer (Merck).
• Triglyceride was assessed with a colorimetric enzymatic method.
• Random blood glucose: was assessed from ﬁngertip blood, at the
time of collecting the blood samples, using a portable glucose
meter (Accu-Check Advantage – Roche).
• C-reactive protein was measured using an Immulite chemiluminescent immunoassay (Siemens). Because the lower detection
limit was 0.1 mg/L, measures below that value were converted
to 0.05 mg/L. Subjects with CRP >10 mg/L were excluded from
the analyses involving CRP, as were pregnant women and those
using oral contraceptives.
With respect to the exposure to maternal smoking in the pregnancy, during the interview at the hospital, the mothers were asked
if they had smoked during the pregnancy. Those mothers who
reported any intake during pregnancy were considered as smokers. Information on the duration of smoking during the pregnancy
(mother stopped smoking during pregnancy or not) and the number of cigarette smoked was also gathered.
Because glucose levels were related to fasting time, glucose estimates were corrected for the time elapsed since the last meal. [10]
A linear regression estimated the mean change in random glucose
according to fasting time. Thereafter, we corrected the glucose estimates.
Information on confounding variables was collected in the early
phases of the study. These included monthly family income, maternal education, household assets index (obtained through factor
analysis and based on the ownership of household goods) and
maternal skin color.
Triglycerides and CRP values (mg/L) were natural logtransformed (lnmg/L) for greater symmetry prior to undertaking
statistical analyses and are presented in the text as the geometric
mean. In the crude analysis, means were compared using analy-

sis of variance. Adjusted analyses, controlling for the above listed
confounders, were carried out using linear regression analysis.
Statistical comparisons between groups were based on tests of heterogeneity and linear trend in the case of ordinal variables, and the
one with the lower P-value was presented.
For those risk factors that were associated to exposure to
maternal smoking in the pregnancy, we also adjusted for possible mediators. The adjustment for mediators followed a stepwise
model, initially perinatal factors (birthweight) were included in
the regression models. Then, adult behavioral factors were also
included (leisure-time physical activity, dietary pattern, intake of
fat and ﬁber, and tobacco smoking) and ﬁnally estimates were
adjusted for adult anthropometry (body mass index and waist
circumference). Information about leisure-time physical activity
was collected using the International Physical Activity Questionnaire. Those with weekly physical activity below 150 min were
considered as sedentary at leisure-time. With respect to dietary
patterns, information on diet in the last 12 months was evaluated
using a Food Frequency Questionnaire. And, a principal component
analysis identiﬁed three main dietary patterns (common Brazilian,
processed food and prudent type).
The study was approved by the Ethical Review Board of the Faculty of Medicine of the Federal University of Pelotas, and written
informed consent was obtained from participating subjects.
3. Results
In the 2004–2005 follow-up visit, 4297 subjects were interviewed. Added to the 282 known to have died, they represented a
follow-up rate of 77.4%. Follow-up rates were independent of birthweight, sex and maternal skin color. On the other hand, children
born at either the upper or lower end of family income distribution
and those whose mother had 12 or more years of schooling were
less likely to be traced in adulthood [11].
Table 1 shows that 14.4% of the subjects evaluated at 23 years
were born small for gestational age, whereas 5.3% were preterm.
And about one of every three subjects was exposed to maternal
smoking during pregnancy. At 23 years, mean systolic blood pressure was 117.5 mmHg and HDL cholesterol was 55.5 mg/dL.
To help interpret the results of the adjusted analyses, it is important to understand the associations between maternal smoking
and confounding/mediating factors, and among the latter and the
outcomes under study. Maternal smoking was inversely associated with family income, maternal education, and household asset
index (Web Table 1). In terms of associations between maternal smoking and potential mediating factors, maternal smoking

Table 1
Distribution of sample studied at 23 years of age, according to key characteristics.
Sample characteristics
At birth
Birthweight (g)
Preterm birth
Small-for-gestational age
Maternal smoking in the pregnancy
No
Stopped smoking during pregnancy
Smoked during whole pregnancy
At 23 years
Triglycerides (mg/dL)a
HDL cholesterol (mg/dL)
Non-fasting glucose (mg/dL)b
Mean systolic blood pressure (mmHg)
Mean diastolic blood pressure (mmHg)
C-reactive proteina
a
b

Geometric mean.
Corrected for fasting time.

N

Mean (SD)

4295
3442
3441

3223 (517)
5.3
14.4

2765
348
1176
3663
3824
3706
4291
4291
3091

Prevalence (%)

64.5
8.1
27.4
91.4 (1.71)
55.5 (13.0)
93.8 (16.1)
117.5 (15.0)
73.6 (11.5)
0.97 (3.32)

Table 2
Metabolic cardiovascular risk factors according to maternal smoking during pregnancy. Unadjusted analyses.

Male
Maternal smoking during pregnancy
No
Yes
Maternal smoking during pregnancy
Non smokers
<15 cig/day
≥15 cig/day
Maternal smoking during pregnancy
Non smokers
Stopped smoking during pregnancy
Smoked during the whole pregnancy
Female
Maternal smoking during pregnancy
No
Yes
Maternal smoking during pregnancy
Non smokers
<15 cig/day
≥15 cig/day
Maternal smoking during pregnancy
Non smokers
Stopped smoking during pregnancy
Smoked during the whole pregnancy
a
b
c

Mean
triglycerides in
mg/dL (SD)a

Mean HDL
cholesterol in
mg/dL (SD)

Mean non-fasting
glucose (SD) in
mg/dL

Mean systolic
blood pressure in
mmHg (SD)

Mean diastolic
blood pressure in
mmHg (SD)

Mean C-reactive
protein (SD)a in
mg/L

P = 0.75
97.6 (1.79)
96.8 (1.76)
P = 0.07b
97.6 (1.79)
99.7 (1.76)
89.0 (1.73)
P = 0.80b
97.6 (1.79)
99.1 (1.72)

P = 0.19
51.8 (11.2)
51.1 (11.2)
P = 0.31b
51.8 (11.2)
50.9 (11.3)
51.7 (11.0)
P = 0.22b
51.8 (11.2)
52.0 (11.5)

P = 0.72
96.2 (16.4)
96.5 (17.2)
P = 0.45b
96.2 (16.4)
96.9 (17.7)
95.1 (15.4)
P = 0.86b
96.2 (16.4)
96.0 (14.7)

P = 0.45
123.7 (14.3)
123.2 (14.4)
P = 0.06b
123.7 (14.3)
122.5 (14.6)
125.1 (13.8)
P = 0.75b
123.7 (14.3)
123.1 (15.2)

P = 0.43
75.8 (11.6)
75.4 (11.8)
P = 0.34b
75.8 (11.6)
75.1 (11.7)
76.3 (12.1)
P = 0.54b
75.8 (11.6)
76.0 (12.1)

P = 0.74
0.79 (3.18)
0.77 (3.16)
P = 0.21b
0.79 (3.18)
0.81 (3.14)
0.68 (3.19)
P = 0.14b
0.79 (3.18)
0.91 (3.10) 0.74
(3.17)

96.1 (1.77)

50.8 (11.1)

96.6 (17.8)

123.2 (14.2)

75.3 (11.7)

P = 0.33
86.6 (1.62)
84.7 (1.61)
P = 0.49b
86.6 (1.62)
84.1 (1.60)
86.8 (1.64)
P = 0.52b
86.6 (1.62)
83.0 (1.58)
85.2 (1.62)

P < 0.001
60.4 (13.6)
57.5 (13.1)
P < 0.001c
60.4 (13.6)
57.7 (13.3)
57.1 (12.4)
P < 0.001c
60.4 (13.6)
59.2 (13.5)
57.1 (12.9)

P = 0.23
91.1 (14.7)
92.0 (15.7)
P = 0.11c
91.1 (14.7)
91.6 (15.5)
93.3 (16.4)
P = 0.47b
91.1 (14.7)
92.2 (16.0)
91.9 (15.6)

P = 0.99
111.1 (12.8)
111.1 (13.4)
P = 0.98b
111.1 (12.8)
111.2 (13.9)
110.9 (11.6)
P = 0.39b
111.1 (12.8)
112.3 (13.7)
110.8 (13.3)

P = 0.39
71.4 (10.4)
71.0 (11.4)
P = 0.31c
71.4 (10.4)
71.1 (11.6)
70.6 (10.4)
P = 0.19b
71.4 (10.4)
72.2 (11.7)
70.7 (11.3)

P = 0.41
1.34 (3.34)
1.26 (3.31)
P = 0.29c
1.34 (3.34)
1.29 (3.26)
1.16 (3.51)
P = 0.55b
1.34 (3.34)
1.17 (3.33)
1.29 (3.31)

Geometric mean.
Test for heterogeneity.
Test for linear trend.

in the pregnancy was positively associated with tobacco smoking
in early adulthood, whereas fat intake was slightly lower among
those subjects whose mother smoked in the pregnancy (Web Table
2). Prevalence of tobacco smoking in early adulthood is inversely
associated with socioeconomic status (Web Table 3). Web Table 4
presents the distribution of the metabolic risk factors of cardiovascular disease according to the confounding variables. Triglycerides,
HDL cholesterol and C-reactive protein were positively associated
with socioeconomic variables, whereas blood pressure was related
to maternal skin color.
In the crude analyses, the only outcome associated with maternal smoking was HDL cholesterol in females, but not in males (P
value for interaction with sex equal to 0.009). Women born to
smoking mothers had lower HDL levels (Table 2).
Table 3 shows that even after controlling for possible confounding variables HDL cholesterol levels were still lower among female
offspring of smokers. Independent of gender, C-reactive protein
was lower among those subjects whose mother smoked 15 or more
cigarettes/day in the pregnancy. The conﬁdence intervals, however,
included the null value, and there was no evidence of an effect
among light smokers, nor was CRP related to duration of exposure
to smoking during pregnancy.
Analyses adjusted for potential mediating factors were carried
out for HDL cholesterol among females, the only association that
persisted in the confounder adjusted analyses. After adjustment for
lifestyle variables in early adulthood (leisure time physical activity,
intake of fat, diet pattern and tobacco smoking), birthweight, and
waist circumference, the difference in HDL levels between female
offspring of smokers and non-smokers reduced from −2.10 mg/dL
(95% conﬁdence interval: −3.39; −0.80) to −1.03 mg/dL (−2.35;
0.30) (Table 4).
4. Discussion
In this cohort that has been followed up since birth, the only
evidence that maternal smoking is associated with the develop-

ment of metabolic cardiovascular risk factors in early adulthood
was the observation that HDL cholesterol was lower among offspring of smokers. Because of the large number of comparisons
included in the analyses, the possibility of a chance ﬁnding cannot be discarded. Also, the disappearance of the association after
adjustment for risk factors measured in young adults suggests that
– if true – the observed association was mediated through contemporary variables, as reported by Power et al. for the 1958 British
cohort [8].
In the 2004–2005 visit, we were not able to locate 22.6% of the
subjects, as previous cited follow-up rate was not related to sex,
maternal skin color and birthweight. However, the attrition rate
was lower among subjects in middle-income group. Because maternal smoking during pregnancy was not related to attrition rate,
selection bias is unlikely to have affected our results. Another possible limitation of the analyses is the young age of subjects, before the
peak age range for cardiovascular diseases. Nevertheless, metabolic
risk factors, such as blood lipids measured in young adults, are
related to a higher risk of cardiovascular disease in midlife. One
cannot rule out the possibility that the effects of maternal smoking on precursors of chronic diseases will only become apparent at
later ages.
Information on maternal smoking during pregnancy was
collected just after delivery, minimizing misclassiﬁcation. Furthermore, information on confounding variables was collected
prospectively, using standardized questionnaires and trained interviewers. One limitation was that lipids and glucose levels were
measured from non-fasting blood, as obtaining fasting samples in
such a large cohort presented major logistic difﬁculties. Whereas
HDL cholesterol is not affected by fasting status [12], triglycerides
vary according to time since last meal and time of day. [13] In
the literature, fasting triglycerides are preferred, mainly due to
lower variability in the measurement and the need to estimate LDL
with Friedwald equation, using HDL cholesterol and triglyceride
levels. [14] However, epidemiological studies have reported that
non-fasting triglycerides predict cardiovascular risk better than

c

b

a

P = 0.85a
0.0 (reference)
0.03 (−2.93; 2.99)
0.18 (−1.65; 2.01)

P = 0.30b
0.0 (reference)
0.85 (−1.10; 2.80)
−0.69 (−1.91; 0.53)
P = 0.002
0.0 (reference)
−2.10 (−3.39; −0.80)
P = 0.002a
0.0 (reference)
−1.92 (−3.33; −0.51)
−2.73 (−5.10; −0.37)
P < 0.001a
0.0 (reference)
−0.50 (−2.81; 1.82)
−2.57 (−3.98; −1.15)

P = 0.57
0.0 (reference)
−0.01 (−0.06; 0.03)
P = 0.62b
0.0 (reference)
−0.02 (−0.07; 0.03)
0.02 (−0.07; 0.10)
P = 0.84b
0.0 (reference)
−0.02 (−0.10; 0.06)
−0.01 (−0.06; 0.04)

P = 0.60
0.0 (reference)
0.40 (−1.12; 1.92)
P = 0.36a
0.0 (reference)
0.03 (−1.61; 1.68)
1.73 (−1.03; 4.49)
P = 0.83b
0.0 (reference)
0.79 (−1.92; 3.49)
0.29 (−1.36; 1.94)

P = 0.86
0.0 (reference)
0.15 (−1.52; 1.82)
P = 0.74b
0.0 (reference)
0.44 (−1.40; 2.29)
−0.73 (−3.57; 2.10)

P = 0.57
0.0 (reference)
−0.32 (−1.43; 0.79)
P = 0.68b
0.0 (reference)
−0.50 (−1.73; 0.72)
0.19 (−1.67; 2.05)

Non-fasting
glucose in mg/dL

P = 0.99
0.0 (reference)
0.00 (−0.06; 0.06)
P = 0.03b
0.0 (reference)
0.03 (−0.03; 0.10)
−0.10 (−0.19;
−0.01)
P = 0.99b
0.0 (reference)
0.01 (−0.09; 0.10)
0.00 (−0.06; 0.06)

Mean HDL
cholesterol in mg/dL

Test for linear trend.
Test for heterogeneity.
Adjusted for: family income at birth, maternal schooling, skin color and household asset index.

Maternal smoking during pregnancy
Non smokers
Stopped smoking during pregnancy
Smoked during the whole pregnancy
Female
Maternal smoking during pregnancy
No
Yes
Maternal smoking during pregnancy
Non smokers
<15 cig/day
≥15 cig/day
Maternal smoking during pregnancy
Non smokers
Stopped smoking during pregnancy
Smoked during the whole pregnancy

Male
Maternal smoking during pregnancy
No
Yes
Maternal smoking during pregnancy
Non smokers
<15 cig/day
≥15 cig/day

Triglycerides in
mg/dL

Adjusted regression coefﬁcient (95% conﬁdence interval)c

Table 3
Adjusted regression coefﬁcients for metabolic cardiovascular risk factors at 23 years according to maternal smoking in the pregnancy.

P = 0.99
0.0 (reference)
0.00 (−1.23; 1.24)
P = 0.99b
0.0 (reference)
−0.02 (−1.35; 1.31)
0.09 (−2.18; 2.36)
P = 0.19b
0.0 (reference)
1.67 (−0.51; 3.85)
−0.50 (−1.84; 0.85)

P = 0.93b
0.0 (reference)
−0.47 (−2.82; 1.88)
−0.04 (−1.49; 1.42)

P = 0.84
0.0 (reference)
−0.14 (−1.47; 1.20)
P = 0.16b
0.0 (reference)
−0.74 (−2.22; 0.73)
1.58 (−0.64; 3.81)

Mean systolic blood
pressure in mmHg

P = 0.57
0.0 (reference)
−0.29 (−1.31; 0.72)
P = 0.50a
0.0 (reference)
−0.21 (−1.31; 0.90)
−0.62 (−2.50; 1.26)
P = 0.05b
0.0 (reference)
1.50 (−0.30; 3.31)
−0.84 (−1.95; 0.28)

P = 0.62b
Reference
0.24 (−1.67; 2.15)
−0.54 (−1.72; 0.65)

P = 0 0.52
0.0 (reference)
−0.36 (−1.44; 0.73)
P = 0.60b
Reference
−0.56 (−1.76; 0.64)
0.23 (−1.59; 2.04)

Mean diastolic blood
pressure in mmHg

P = 0.35
0.0 (reference)
−0.07 (−0.22; 0.08)
P = 0.20a
0.0 (reference)
−0.04 (−0.20; 0.12)
−0.20 (−0.47; 0.07)
P = 0.64b
0.0 (reference)
−0.08 (−0.35; 0.18)
−0.07 (−0.23; 0.09)

P = 0.24b
0.0 (reference)
0.15 (−0.06; 0.35)
−0.04 (−0.17; 0.09)

P = 0.95
0.0 (reference)
0.00 (−0.11; 0.12)
P = 0.10b
0.0 (reference)
0.06 (−0.07; 0.19)
−0.17 (−0.37; 0.03)

C-reactive protein
in mg/L
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Table 4
Adjusted regression coefﬁcients for HDL cholesterol at 23 years according to maternal smoking in the pregnancy, for females.
Adjusted regression coefﬁcient (HDL cholesterol in mg/dL)

Maternal smoking in the pregnancy
No
Yes
Maternal smoking in the pregnancy
No
<15 cig/day
≥15 cig/day
Maternal smoking in the pregnancy
No
Stopped smoking during pregnancy
Smoked during the whole pregnancy

Adjusted for confounding

1 + birth weight

2 + lifestyle 23 years

3 + Body mass index and
waist circumference

P = 0.002
0.0 (reference)
−2.10 (−3.39; −0.80)
P = 0.002*
0.0 (reference)
−1.92 (−3.33; −0.51)
−2.73 (−5.10; −0.37)
P < 0.001*
0.0 (reference)
−0.50 (−2.80; 1.83)
−2.57 (−3.98; −1.15)

P = 0.02
0.0 (reference)
−1.62 (−2.94; −0.31)
P = 0.02*
0.0 (reference)
−1.53 (−2.95; −0.12)
−1.97 (−4.35; 0.42)
P = 0.007*
0.0 (reference)
−0.30 (−2.61; 2.01)
−2.02 (−3.46; −0.59)

P = 0.08
0.0 (reference)
−1.16 (−2.47; 0.15)
P = 0.06*
0.0 (reference)
−0.99 (−2.39; 0.42)
−1.83 (−4.23; 0.57)
P = 0.06*
0.0 (reference)
−0.40 (−2.70; 1.89)
−1.39 (−2.82; 0.05)

P = 0.13
0.0 (reference)
−1.03 (−2.35; 0.30)
P = 0.13*
0.0 (reference)
−0.95 (−2.38; 0.47)
−1.31 (−3.75; 1.13)
P = 0.12*
0.0 (reference)
−0.66 (−2.98; 1.67)
−1.14 (−2.60; 0.32)

1. Adjusted for family income at birth, maternal schooling, skin color and household asset index.
2. Adjusted for family income at birth, maternal schooling, skin color, household asset index and birthweight.
3. Adjusted for family income at birth, maternal schooling, skin color, household asset index, birthweight and lifestyle variables at 23 years.
*
Test for linear trend.

fasting levels. [15–18] Therefore, the use of non-fasting samples
is acceptable in this analysis on the programming of metabolic cardiovascular risk factors by maternal smoking in pregnancy. With
respect to blood glucose, time since last meal was not related to
maternal smoking during pregnancy, and, therefore, the use of nonfasting samples introduced a non-differential classiﬁcation bias.
Because, no pattern that would suggest an association between
maternal smoking during pregnancy and blood glucose levels in
adulthood was observed, this classiﬁcation bias cannot be considered as responsible for the lack of association between maternal
smoking and blood glucose levels.
As mentioned, the evidence on the long-term effect of maternal
smoking during pregnancy on metabolic cardiovascular risk factors
is controversial. A meta-analysis observed a small increase in blood
pressure among offspring of smokers, [5] but the ﬁndings of similar
effects of both paternal and maternal smoking on blood pressure
[7] and the strong reduction in the magnitude of the association
between maternal smoking and offspring cardiovascular risk factors in adulthood after adjustment for lifestyle variables [8] raised
the issue that the observed long-term effect was a marker of familial factors that are related to lifestyle risk factors of cardiovascular
disease.
Indeed, the prevalence of lifestyle cardiovascular risk factors
tends to be higher among offspring of smoking parents. A literature
review reported that parental smoking was positively associated
with smoking in adolescence, [19] whereas another study observed
that maternal smoking in pregnancy was related to smoking in
girls but not in boys. [20] With respect to diet, maternal smoking has been related to breastfeeding duration [21], as well as to
diet quality and physical activity in childhood and adolescence.
[22–24] Nevertheless, existing data suggest that such association
is not due to prenatal exposure to smoking, but more likely due to
intergenerational transmission of health behaviors.
To conclude there are little evidence that maternal smoking
during pregnancy program offspring metabolic cardiovascular risk
factors, and reported associations are likely due to postnatal exposure to lifestyle patterns.
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